z-logo
Premium
Differentiation of subgroups of monosymptomatic enuresis according to prepulse inhibition of the startle reflex
Author(s) -
Eggert Paul,
Freischmidt Sönke,
Bismarck Phillip v.,
SchulzJürgensen Sebastian
Publication year - 2012
Publication title -
acta paediatrica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 115
eISSN - 1651-2227
pISSN - 0803-5253
DOI - 10.1111/j.1651-2227.2012.02624.x
Subject(s) - medicine , prepulse inhibition , enuresis , reflex , moro reflex , audiology , anesthesia , pediatrics , psychiatry , schizophrenia (object oriented programming)
Aim:  Monosymptomatic enuresis (ME) is a common disorder in children with serious social and psychological consequences. Treatment is usually initiated with desamino‐arginine vasopressin (dDAVP) and/or alarm therapy as first‐line treatment and imipramine as second‐line. All treatments have proven efficacy, but are not successful with all patients. Therefore, a differentiation into subgroups according to treatment efficacy would be beneficial. Methods:  A group of patients resistant to first‐line treatment was treated with imipramine and compared with matched controls successfully treated with dDAVP and/or alarm therapy. Prepulse inhibition (PPI) to acoustic startle reflexes was measured in all patients. Results:  In a group of 23 nonresponders, the median PPI was 72% (range 43–94%) compared with the matched dDAVP/alarm – responders with a median PPI of 26% (range 0–61%) (p < 0.0001). The response rate to imipramine was 87%. Conclusion:  The presented data provide evidence that PPI allows to identify two subgroups of ME. The results offer further insight into (at least) two different pathomechanisms involved in ME: (i) a maturational delay of reflex inhibition with reduced PPI and (ii) a normal PPI, possibly with abnormal sleep patterns, that can be influenced by imipramine.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here